Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 43063-453

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 43063-453). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

43063453 Label (43063453)

43063453 Label (43063453)
This is a description for a medication named Atorvastatin Calcium USP. Each tablet contains 40mg of Atorvastatin Calcium. The medication comes in a bottle of 30 tablets with a LOT number of D20B58 and an EXP date of 04/2022. The recommended dosage is to take the tablet/s several times a day. The tablet/s are marked with the identifier APO ATV 40. Side-effects can be reported to FDA at 1-800-FDA-1088.*
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
This is a table or graph displaying the cumulative hazard percentage for Atorvastatin over the course of four years of follow-up. The hazard ratio for Atorvastatin is 0.53 with a confidence interval of 0.45 to 0.83. There are also numbers 1 through 5 indicating the time to the first primary endpoint.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
The text describes a chart or a graph that shows the percentage of subjects who experienced "E vert" in a study involving different medications. The medications compared were Horvastatin 10 mg and Sorvastatin 80 mg. The chart also shows a statistical value, HR which is 0.78 for the Horvastatin group and a P-value. Additionally, there is a graph or plot that shows the time to the first major cardiovascular endpoint in years.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.